January 30, 2014
In this 2014 video, Dr. Hwang talks about using updated CAP protocols for the lung and lung biomarker
Watch as Dr. David Hwang talks about using the updated CAP protocols for the lung, with a focus on changes since the last version. He also talks about targetable molecular alterations in lung cancer and the lung biomarker checklist.
David Hwang, MD, PhD, FRCPC, is a Pathologist at University Health Network (UHN) and an Associate Professor in the Department of Laboratory Medicine & Pathobiology at the University of Toronto, Ontario, Canada. He completed his MD and PhD degrees at the University of Toronto, followed by residency training in Anatomical Pathology.
Watch the video for the CAP education session about lung cancer
The Partnership, the Canadian Association of Pathologists (CAP-ACP) and Pediatric Oncology Group of Ontario (POGO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.